Virtus Investment Advisers, Inc. Harmony Biosciences Holdings, Inc. Transaction History
Virtus Investment Advisers, Inc.
- $119 Million
- Q4 2024
A detailed history of Virtus Investment Advisers, Inc. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 3,600 shares of HRMY stock, worth $124,416. This represents 0.1% of its overall portfolio holdings.
Number of Shares
3,600Holding current value
$124,416% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
255Shares Held
46.6MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$229 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$202 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$164 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$78.8 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$54.6 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.04B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...